Pharmacyclics, Inc.
(NASDAQ : PCYC)

( )
PCYC PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Loading PCYC News...
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
-0.31%34.911.4%$910.58m
JNJJohnson & Johnson
-0.17%119.100.8%$876.59m
ABBVAbbVie, Inc.
0.00%61.801.7%$588.13m
MRKMerck & Co., Inc.
0.00%57.021.0%$558.87m
BMYBristol-Myers Squibb Company
0.00%72.971.1%$480.65m
LLYEli Lilly and Company
0.00%78.140.8%$367.90m
GSKGlaxoSmithKline plc Sponsored ADR
-0.27%42.350.2%$178.93m
NVSNovartis AG Sponsored ADR
0.00%81.170.2%$158.94m
AZNAstraZeneca PLC Sponsored ADR
-1.24%29.470.9%$152.47m
SNYSanofi Sponsored ADR
0.00%41.300.2%$103.20m
NVONovo Nordisk A/S Sponsored ADR Class B
0.00%52.990.1%$85.43m
LCILannett Company, Inc.
0.00%23.6627.9%$17.01m
SCMPSucampo Pharmaceuticals, Inc. Class A
0.00%10.854.1%$6.08m
AKTXAkari Therapeutics Plc Sponsored ADR
-6.80%13.550.2%$0.07m
EPIXESSA Pharma Inc
0.00%2.900.0%$0.01m

Company Profile

Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. The company has three product candidates in clinical development and several preclinical molecules in lead optimization. Its clinical development and product candidates are small-molecule enzyme inhibitors designed to target key biochemical pathways involved in human diseases with critical unmet needs. Pharmacyclics was founded on April 19, 1991 and is headquartered in Sunnyvale, CA.